GRN and acute myeloid leukemia: In hematopoietic malignancy, patients with acute myeloid leukemia who reached complete remission showed significantly decreased plasma progranulin levels after treatment, although there were no changes in plasma progranulin levels among patients who did not achieve complete remission [17].